Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

83.23
Delayed Data
As of Feb 12
 +3.52 / +4.42%
Today’s Change
78.51
Today|||52-Week Range
143.45
-33.86%
Year-to-Date

Today’s Trading

Previous close79.71
Today’s open81.94
Day’s range79.50 - 83.81
Volume2,771,696
Average volume (3 months)2,239,754
Market cap$20.5B
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+142.53%
Earnings growth (next 5 years)+61.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book18.76

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.41+0.98%
PRGOPerrigo Company PLC+3.53+2.61%
ZTSZoetis Inc+1.07+2.72%
INCYIncyte Corp+2.85+4.35%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.0B
Annual profit (last year)-$558.1M
Net profit margin-54.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers